AI assistant
Sending…
Structure Therapeutics Inc. — Director's Dealing 2024
Jun 13, 2024
31940_dirs_2024-06-13_581486c6-1d7c-4c37-9870-2a0681db053a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2024-06-06
Reporting Person: FMR LLC (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 45120 | Indirect |
| Ordinary Shares | 530814 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| American Depositary Shares | $ | Ordinary Shares (4625604) | Indirect | ||
| American Depositary Shares | $ | Ordinary Shares (123) | Indirect | ||
| American Depositary Shares | $ | Ordinary Shares (4095) | Indirect | ||
| American Depositary Shares | $ | Ordinary Shares (48249) | Indirect |
Footnotes
F1: Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice.
More from Structure Therapeutics Inc.
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 23
Regulatory Filings
2026
Apr 15
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 5
Director's Dealing
2026
Jan 20